Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-25-000816
Filing Date
2025-05-15
Accepted
2025-05-15 14:29:09
Documents
52
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pktx_10q.htm   iXBRL 10-Q 448213
2 WARRANT AGREEMENT ex4x5.htm EX-4.5 54111
3 EXHIBIT 31.1 ex31x1.htm EX-31.1 11734
4 EXHIBIT 31.2 ex31x2.htm EX-31.2 11626
5 EXHIBIT 32.1 ex32x1.htm EX-32 6141
  Complete submission text file 0001079973-25-000816.txt   2660700

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pktx-20250331.xsd EX-101.SCH 24522
7 XBRL CALCULATION FILE pktx-20250331_cal.xml EX-101.CAL 23489
8 XBRL DEFINITION FILE pktx-20250331_def.xml EX-101.DEF 80633
9 XBRL LABEL FILE pktx-20250331_lab.xml EX-101.LAB 172037
10 XBRL PRESENTATION FILE pktx-20250331_pre.xml EX-101.PRE 143682
54 EXTRACTED XBRL INSTANCE DOCUMENT pktx_10q_htm.xml XML 334887
Mailing Address 109 W. MAIN ST. DALTON OH 44618
Business Address 109 W. MAIN ST. DALTON OH 44618 330-445-4971
ProtoKinetix, Inc. (Filer) CIK: 0001128189 (see all company filings)

EIN.: 943355026 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32917 | Film No.: 25951484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)